Clinical Trial Update: Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)

View source ↗

Summary

A completed clinical trial update evaluating risk stratification and benefits of Cardiac Resynchronization Therapy (CRT) in patients with heart failure and vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Arrhythmias

Drugs mentioned

• Cardiac Resynchronization Therapy device

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Ventricular Arrhythmias | Status: COMPLETED